GenTrust’s Tenet Healthcare THC Stock Holding History

GenTrust’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,130	Closed	-$213K	–	288
2026 Q1	$213K	Sell	1,130 -3,946	-78%	-$831K	0.01%	264
2025 Q4	$1.01M	Buy	5,076 +670	+15%	+$135K	0.04%	117
2025 Q3	$895K	Buy	+4,406	New	+$782K	0.04%	111

Other funds holding THC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

GenTrust's THC Position: Q2 2026 in Review

GenTrust sold out of Tenet Healthcare (THC) in Q2 2026, closing a stake of 1,130 shares — an estimated $213K sold.

GenTrust first reported a position in THC in Q3 2025 and held it in 3 quarters. The position peaked at $1.01M in Q4 2025. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

GenTrust reported no remaining Tenet Healthcare position as of Q2 2026 after selling out during the quarter.
GenTrust sold 1,130 Tenet Healthcare shares in Q2 2026, an estimated $213K.
GenTrust first reported a position in Tenet Healthcare in Q3 2025 and held it in 3 quarters.
GenTrust's Tenet Healthcare position peaked at $1.01M in Q4 2025.
679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on GenTrust's 13F filing for Q2 2026, filed 6 Aug 2026.